MX2023004034A - Métodos de tratamiento de la dermatomiositis. - Google Patents
Métodos de tratamiento de la dermatomiositis.Info
- Publication number
- MX2023004034A MX2023004034A MX2023004034A MX2023004034A MX2023004034A MX 2023004034 A MX2023004034 A MX 2023004034A MX 2023004034 A MX2023004034 A MX 2023004034A MX 2023004034 A MX2023004034 A MX 2023004034A MX 2023004034 A MX2023004034 A MX 2023004034A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- dermatomyositis
- treating
- treating dermatomyositis
- composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063087577P | 2020-10-05 | 2020-10-05 | |
| PCT/US2021/053540 WO2022076388A1 (en) | 2020-10-05 | 2021-10-05 | Methods of treating dermatomyositis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023004034A true MX2023004034A (es) | 2023-06-09 |
Family
ID=81126239
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023004034A MX2023004034A (es) | 2020-10-05 | 2021-10-05 | Métodos de tratamiento de la dermatomiositis. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230357442A1 (https=) |
| EP (1) | EP4225372A4 (https=) |
| JP (1) | JP2023544409A (https=) |
| KR (1) | KR20230084210A (https=) |
| CN (1) | CN116472065A (https=) |
| AU (1) | AU2021358027A1 (https=) |
| CA (1) | CA3172994A1 (https=) |
| IL (1) | IL301713A (https=) |
| MX (1) | MX2023004034A (https=) |
| WO (1) | WO2022076388A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116313071B (zh) * | 2023-01-16 | 2023-09-08 | 南方医科大学南方医院 | 一种预测初诊皮肌炎患者发生快速进展型间质性肺病的风险模型的构建方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2794359A (en) * | 1953-09-22 | 1957-06-04 | Lyman Gun Sight Corp | Automatic primer feed device |
| JP5809242B2 (ja) * | 2010-04-21 | 2015-11-10 | アッヴィ バイオテクノロジー リミテッド | 治療薬の制御送達のための装着型自動注入装置 |
| EP3511339B1 (en) * | 2012-02-20 | 2025-04-09 | IPC Research, LLC | Polypeptides binding to human complement c5 |
| CN108476328B (zh) * | 2016-01-04 | 2021-04-20 | 瑞典爱立信有限公司 | 改进的网络记录设备 |
| KR102806328B1 (ko) * | 2017-07-11 | 2025-05-14 | 알렉시온 파마슈티칼스, 인코포레이티드 | 보체 성분 c5 또는 혈청 알부민에 결합하는 폴리펩티드 및 그의 융합 단백질 |
| BR112021018456A2 (pt) * | 2019-03-22 | 2021-11-23 | Achillion Pharmaceuticals Inc | Compostos farmacêuticos para o tratamento de distúrbios mediados por complemento |
| AU2022283254A1 (en) * | 2021-05-25 | 2023-11-30 | Alexion Pharmaceuticals, Inc. | Kidney active fusion proteins and methods of treatment using the same |
| JP2024534083A (ja) * | 2021-08-20 | 2024-09-18 | アレクシオン ファーマシューティカルズ, インコーポレイテッド | 補体代替経路阻害剤を用いて鎌状赤血球症又はベータサラセミアを治療する方法 |
-
2021
- 2021-10-05 IL IL301713A patent/IL301713A/en unknown
- 2021-10-05 CA CA3172994A patent/CA3172994A1/en active Pending
- 2021-10-05 MX MX2023004034A patent/MX2023004034A/es unknown
- 2021-10-05 EP EP21878348.8A patent/EP4225372A4/en not_active Withdrawn
- 2021-10-05 KR KR1020237014973A patent/KR20230084210A/ko not_active Withdrawn
- 2021-10-05 AU AU2021358027A patent/AU2021358027A1/en not_active Abandoned
- 2021-10-05 US US18/029,525 patent/US20230357442A1/en active Pending
- 2021-10-05 WO PCT/US2021/053540 patent/WO2022076388A1/en not_active Ceased
- 2021-10-05 JP JP2023520448A patent/JP2023544409A/ja active Pending
- 2021-10-05 CN CN202180076442.2A patent/CN116472065A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20230084210A (ko) | 2023-06-12 |
| CA3172994A1 (en) | 2022-04-14 |
| WO2022076388A1 (en) | 2022-04-14 |
| CN116472065A (zh) | 2023-07-21 |
| IL301713A (en) | 2023-05-01 |
| EP4225372A1 (en) | 2023-08-16 |
| US20230357442A1 (en) | 2023-11-09 |
| JP2023544409A (ja) | 2023-10-23 |
| AU2021358027A1 (en) | 2023-05-11 |
| EP4225372A4 (en) | 2024-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JOP20200309A1 (ar) | أجسام مضادة لـ il-11 | |
| CL2021002669A1 (es) | (divisional de solicitud 3443-2018) tratamientos de cancer. | |
| MX392869B (es) | Kit para el tratamiento o alivio de dolor en el sitio de incision despues de un procedimiento quirurgico | |
| ZA202202363B (en) | Antibodies against ilt2 and use thereof | |
| EP4497474A3 (en) | Methods of treating rheumatic diseases using trimetazidine-based compounds | |
| SG11201806502UA (en) | Conjugate of therapeutic enzymes | |
| EP4338804A3 (en) | Epinephrine spray formulations | |
| SA523440622B1 (ar) | أجسام مضادة | |
| PH12020551076A1 (en) | Methods for treating diabetes, hepatitis, and/or inflammatory liver disease | |
| PH12022550130A1 (en) | Enzyme inhibitors | |
| MX2020011817A (es) | Metodos para tratar el linfoma. | |
| MX2019001958A (es) | Metodos para tratar la enfermedad de crohn con un anticuerpo anti-nkg2d. | |
| PH12020550340A1 (en) | Anti-pacap antibody | |
| MX2023004933A (es) | Proteinas de fusion de ace2 y usos de las mismas. | |
| MX2024001211A (es) | Proteinas de fusion fc heterodimericas il15/il15r alfa para el tratamiento de tipos de cancer de sangre. | |
| WO2018189661A3 (en) | Methods and compounds for treating diabetes | |
| MX2022004755A (es) | Inyector intravitreo. | |
| WO2021056025A3 (en) | Anti-epha10 antibodies and methods of use thereof | |
| MY200161A (en) | Bacteria for targeting tumors and treating cancer | |
| MX2023006087A (es) | Formulaciones liofilizadas de tegavivint. | |
| MX2021002818A (es) | Métodos para tratar el cáncer mediante la inhibición de la enzima conjugadora de ubiquitina e2 k (ube2k). | |
| MX2023004034A (es) | Métodos de tratamiento de la dermatomiositis. | |
| EA202090558A1 (ru) | Схемы лечения | |
| PH12021551276A1 (en) | Combination therapy for the treatment of cancer | |
| MX2025004900A (es) | Tratamiento de verrugas |